NeoProteomics Overview

  • Founded
  • 2006
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $300K
Latest Deal Amount
  • Investors
  • 4

NeoProteomics General Information


Provider of research services and tools intended to help clients unravel the complexities of pharmaceutical and biological research. The company's research services and tools include mass spectrometry and network biology with a special interest in cancer and neural degeneration, enabling partner companies and research laboratories to get analysis tools for predicting the biological bases of diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 11000 Euclid Avenue
  • Cleveland, OH 44106
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeoProteomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 03-Aug-2011 $300K Completed Generating Revenue
2. Accelerator/Incubator 25-Mar-2011 Completed Generating Revenue
1. Grant 11-Sep-2009 $25K Completed Startup
To view NeoProteomics’s complete valuation and funding history, request access »

NeoProteomics Executive Team (3)

Name Title Board Seat Contact Info
John Schenkel Jr. Co-Founder, President & Chief Executive Officer
Mark Chance Ph.D Co-Founder & Chief Scientific Officer
Steven Chance Secretary & General Counsel
To view NeoProteomics’s complete executive team members history, request access »

NeoProteomics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeoProteomics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Great Lakes Innovation and Development Enterprise Accelerator/Incubator Minority 000 0000 000000 0
Innovation Fund of Northeast Ohio Accelerator/Incubator Minority 000 0000 000000 0
Lorain County Community College Foundation Limited Partner 000 0000 000000 0
To view NeoProteomics’s complete investors history, request access »